CN108452369B - Preparation method of medical adhesive with high antibacterial performance - Google Patents
Preparation method of medical adhesive with high antibacterial performance Download PDFInfo
- Publication number
- CN108452369B CN108452369B CN201810642868.XA CN201810642868A CN108452369B CN 108452369 B CN108452369 B CN 108452369B CN 201810642868 A CN201810642868 A CN 201810642868A CN 108452369 B CN108452369 B CN 108452369B
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- antibacterial
- antibacterial component
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 189
- 239000000853 adhesive Substances 0.000 title claims abstract description 63
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 75
- -1 poly (alpha-cyano isobutyl Chemical group 0.000 claims abstract description 51
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 26
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 26
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 26
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 26
- 229920002258 tannic acid Polymers 0.000 claims abstract description 26
- 229940033123 tannic acid Drugs 0.000 claims abstract description 26
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 25
- 239000000243 solution Substances 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000004814 polyurethane Substances 0.000 claims abstract description 22
- 229920002635 polyurethane Polymers 0.000 claims abstract description 22
- 239000003112 inhibitor Substances 0.000 claims abstract description 21
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 21
- 229920005610 lignin Polymers 0.000 claims abstract description 19
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000661 sodium alginate Substances 0.000 claims abstract description 18
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 18
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 18
- 238000003756 stirring Methods 0.000 claims abstract description 18
- 239000003381 stabilizer Substances 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 14
- 229920001195 polyisoprene Polymers 0.000 claims abstract description 13
- 239000008223 sterile water Substances 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- 238000001816 cooling Methods 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 8
- 229940065472 octyl acrylate Drugs 0.000 claims abstract description 6
- 238000004806 packaging method and process Methods 0.000 claims abstract description 4
- 238000007789 sealing Methods 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 143
- 239000003814 drug Substances 0.000 claims description 30
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 21
- 235000008708 Morus alba Nutrition 0.000 claims description 21
- 240000000249 Morus alba Species 0.000 claims description 21
- 235000013399 edible fruits Nutrition 0.000 claims description 21
- 235000007425 Aronia melanocarpa Nutrition 0.000 claims description 20
- 240000005662 Aronia melanocarpa Species 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 19
- 229910021389 graphene Inorganic materials 0.000 claims description 18
- 244000302661 Phyllostachys pubescens Species 0.000 claims description 17
- 235000003570 Phyllostachys pubescens Nutrition 0.000 claims description 17
- 241001113925 Buddleja Species 0.000 claims description 16
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 15
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 14
- 229910052709 silver Inorganic materials 0.000 claims description 13
- 239000004332 silver Substances 0.000 claims description 13
- 241000207199 Citrus Species 0.000 claims description 12
- 241000501743 Gentiana macrophylla Species 0.000 claims description 12
- 235000020971 citrus fruits Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 235000001405 Artemisia annua Nutrition 0.000 claims description 11
- 240000000011 Artemisia annua Species 0.000 claims description 11
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 11
- 229960003260 chlorhexidine Drugs 0.000 claims description 11
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 11
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 claims description 11
- 235000011477 liquorice Nutrition 0.000 claims description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims 4
- 241000219099 Parthenocissus quinquefolia Species 0.000 claims 1
- 241000229143 Hippophae Species 0.000 abstract description 24
- 230000000694 effects Effects 0.000 description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 239000000463 material Substances 0.000 description 26
- 241000894006 Bacteria Species 0.000 description 22
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 235000013824 polyphenols Nutrition 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- 239000002994 raw material Substances 0.000 description 14
- 241000563984 Ampelopsis Species 0.000 description 13
- 241000588724 Escherichia coli Species 0.000 description 13
- 229930003935 flavonoid Natural products 0.000 description 13
- 235000017173 flavonoids Nutrition 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 241000191967 Staphylococcus aureus Species 0.000 description 12
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallyl group Chemical group C1(=C(C(=CC=C1)O)O)O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 230000003110 anti-inflammatory effect Effects 0.000 description 11
- 150000002215 flavonoids Chemical class 0.000 description 11
- 230000004054 inflammatory process Effects 0.000 description 11
- 206010061218 Inflammation Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 10
- 229960002152 chlorhexidine acetate Drugs 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 239000003755 preservative agent Substances 0.000 description 9
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 229930182558 Sterol Natural products 0.000 description 8
- 239000003242 anti bacterial agent Substances 0.000 description 8
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 8
- 229940091173 hydantoin Drugs 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 8
- 239000012982 microporous membrane Substances 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- 230000002335 preservative effect Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- 235000003702 sterols Nutrition 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 230000000975 bioactive effect Effects 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 150000004804 polysaccharides Chemical class 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 150000003648 triterpenes Chemical class 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 241000191940 Staphylococcus Species 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- WKFQMDFSDQFAIC-UHFFFAOYSA-N 2,4-dimethylthiolane 1,1-dioxide Chemical compound CC1CC(C)S(=O)(=O)C1 WKFQMDFSDQFAIC-UHFFFAOYSA-N 0.000 description 5
- KECOIASOKMSRFT-UHFFFAOYSA-N 2-amino-4-(3-amino-4-hydroxyphenyl)sulfonylphenol Chemical compound C1=C(O)C(N)=CC(S(=O)(=O)C=2C=C(N)C(O)=CC=2)=C1 KECOIASOKMSRFT-UHFFFAOYSA-N 0.000 description 5
- 241000123835 Ampelopsis japonica Species 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 5
- 230000003467 diminishing effect Effects 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 150000003432 sterols Chemical class 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 229920001651 Cyanoacrylate Polymers 0.000 description 4
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 4
- 241001553700 Euphorbia lathyris Species 0.000 description 4
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010668 complexation reaction Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 230000002439 hemostatic effect Effects 0.000 description 4
- 235000008777 kaempferol Nutrition 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 238000011056 performance test Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229940079877 pyrogallol Drugs 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 230000008470 skin growth Effects 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 3
- 108010036949 Cyclosporine Proteins 0.000 description 3
- 235000003935 Hippophae Nutrition 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 229940124350 antibacterial drug Drugs 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 229960001265 ciclosporin Drugs 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229930182912 cyclosporin Natural products 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000001699 photocatalysis Effects 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 229930182734 Sanggenon Natural products 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000003373 anti-fouling effect Effects 0.000 description 2
- 229960004191 artemisinin Drugs 0.000 description 2
- 229930101531 artemisinin Natural products 0.000 description 2
- FIHJKUPKCHIPAT-AHIGJZGOSA-N artesunate Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@@H](OC(=O)CCC(O)=O)[C@@H]4C FIHJKUPKCHIPAT-AHIGJZGOSA-N 0.000 description 2
- 229960004991 artesunate Drugs 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000002041 carbon nanotube Substances 0.000 description 2
- 229910021393 carbon nanotube Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- MUUDYSFWQUSAOO-UHFFFAOYSA-N cudraflavone C Chemical compound CC(C)=CCC=1C(=O)C2=C(O)C(CC=C(C)C)=C(O)C=C2OC=1C1=CC=C(O)C=C1O MUUDYSFWQUSAOO-UHFFFAOYSA-N 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 150000004141 diterpene derivatives Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000214 effect on organisms Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 229930182489 iridoid glycoside Natural products 0.000 description 2
- 150000008145 iridoid glycosides Chemical class 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 230000008338 local blood flow Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 2
- 235000009498 luteolin Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229930015704 phenylpropanoid Natural products 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 229930009674 sesquiterpene lactone Natural products 0.000 description 2
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- 235000015988 Acer ginnala Nutrition 0.000 description 1
- 244000102051 Acer ginnala Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000123846 Buddleja officinalis Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 229930185597 Euphorbia lathyris Natural products 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 244000173782 Ficus hirta Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 244000299452 Gouania lupuloides Species 0.000 description 1
- 235000000292 Gouania lupuloides Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 240000003915 Lophatherum gracile Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- UWQYBLOHTQWSQD-UHFFFAOYSA-N Mulberrin Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2CC=C(C)C)=O)=C1OC=2C1=CC=C(O)C=C1O UWQYBLOHTQWSQD-UHFFFAOYSA-N 0.000 description 1
- MQYYTNPXQXSQGM-IUXPMGMMSA-N Mulberrofuran A Natural products COC1=CC(O)=CC(C=2OC3=CC(O)=CC=C3C=2)=C1C\C=C(\C)CCC=C(C)C MQYYTNPXQXSQGM-IUXPMGMMSA-N 0.000 description 1
- GOBAQYCCUYZMJY-DKEHAURLSA-N Mulberrofuran K Natural products Oc1c2[C@H]3[C@@H]4[C@](c5c6OC(C)(C)C=Cc6c(O)cc5)(Oc2cc(-c2oc5c(c2)ccc(O)c5)c1)Oc1c([C@H]4CC(C)=C3)ccc(O)c1 GOBAQYCCUYZMJY-DKEHAURLSA-N 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241001560086 Pachyrhizus Species 0.000 description 1
- 241001505935 Phalaenopsis Species 0.000 description 1
- 241000123113 Phellinus igniarius Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000207844 Scrophulariaceae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OBNDGIHQAIXEAO-UHFFFAOYSA-N [O].[Si] Chemical compound [O].[Si] OBNDGIHQAIXEAO-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008970 bacterial immunity Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000035587 bioadhesion Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010685 fatty oil Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000000652 homosexual effect Effects 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910001411 inorganic cation Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000002646 long chain fatty acid esters Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- 229930186407 mulberrofuran Natural products 0.000 description 1
- MQYYTNPXQXSQGM-CAOOACKPSA-N mulberrofuran A Chemical compound COC1=CC(O)=CC(C=2OC3=CC(O)=CC=C3C=2)=C1C\C=C(/C)CCC=C(C)C MQYYTNPXQXSQGM-CAOOACKPSA-N 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910017059 organic montmorillonite Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000007146 photocatalysis Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 125000004151 quinonyl group Chemical group 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- UWYZHKAOTLEWKK-UHFFFAOYSA-N tetrahydro-isoquinoline Natural products C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 1
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/108—Elemental carbon, e.g. charcoal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L2300/206—Biguanides, e.g. chlorohexidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a preparation method of a medical adhesive with high antibacterial performance, which is characterized by comprising the following steps: step one, adding sodium alginate, lignin, tannic acid and a stabilizer into sterile water according to the proportion of parts, heating to 100 ℃, stirring for dissolving for 150min, and cooling to room temperature to obtain an aqueous solution A; step two, adding poly (alpha-cyano isobutyl acrylate-alpha-cyano octyl acrylate), polyurethane and polyisoprene into the sea buckthorn seed oil according to the parts ratio, heating to 80 ℃, stirring for 75min, and cooling to room temperature to obtain a sea buckthorn seed oil solution B; step three, uniformly mixing the aqueous solution A and the seabuckthorn seed oil solution B, adding the efficient antibacterial component and the formaldehyde inhibitor according to the proportion by parts, and stirring for 4 hours; and step four, filtering and sterilizing the product obtained in the step three, subpackaging, sealing and packaging to obtain the medical adhesive with high antibacterial performance.
Description
Technical Field
The invention belongs to the technical field of medical materials, and particularly relates to a medical adhesive with high antibacterial performance and a preparation method thereof.
Background
With medical advances, clinical requirements for surgical techniques and the effects of auxiliary materials are becoming higher and higher. The modern medical idea is to reduce the pain of the patient to the maximum extent and recover the patient at the highest speed, the medical adhesive is a branch of medical macromolecules, biological tissues are taken as an adhesive object, and most tissues and organs of a human body can be partially sutured and ligated by using an adhesive technology without anesthesia in the treatment process; the wound is automatically dropped after healing. Compared with the traditional method, the use of the medical adhesive can effectively shorten the operation time and reduce the pain of the patient.
The main research direction of the current medical adhesive is to improve the bonding strength of various adhesives, however, the biomedical materials applied in the current surgical operation have no bacterial immunity function, are easy to adhere and reproduce bacteria, become the infection source of surrounding tissues, bring huge mental and economic pressure to patients, and endow the medical materials with antibacterial activity is the only effective way for solving the problem. The generation of formaldehyde in the storage and use processes of cyanoacrylate medical adhesive has side effects on organism tissues, and the damage to organisms is increased along with the increase of the concentration of the formaldehyde, thereby seriously influencing the effect and the application of the medical adhesive.
Disclosure of Invention
Based on the prior art, the invention aims to provide a medical adhesive which combines a plurality of effective antibacterial components to greatly improve the antibacterial effect, effectively inhibit formaldehyde generation, avoid wound infection and stimulation to biological tissues and has high antibacterial performance, and a preparation method thereof.
The purpose of the invention is realized by the following technical scheme:
the medical adhesive with high antibacterial performance is characterized by comprising the following components in parts by weight: 45-55 parts of poly (alpha-isobutyl cyanoacrylate-alpha-octyl cyanoacrylate), 24-36 parts of efficient antibacterial component, 2-5 parts of polyurethane, 20-25 parts of polyisoprene, 2-4 parts of sodium alginate, 3-6 parts of lignin, 7-10 parts of tannic acid, 1 part of stabilizer, 1 part of formaldehyde inhibitor, 150 parts of sea-buckthorn seed oil and 180 parts of sterile water;
the high-efficiency antibacterial component comprises 5 parts of specific nano antibacterial component, 12-18 parts of natural antibacterial component and 5-10 parts of traditional Chinese medicine antibacterial component;
the specific nano antibacterial component is prepared by mixing silver-loaded nano titanium dioxide, chlorhexidine acetate-montmorillonite and graphene oxide according to the weight part ratio of 2:2: 1;
the natural antibacterial component comprises 2 parts of a butterfly fruit extract, 2 parts of a aronia melanocarpa extract, 3 parts of a sweet wormwood herb extract, 2 parts of a mulberry bark extract, 2 parts of a citrus peel extract and 2 parts of a moso bamboo leaf extract in parts by weight;
the traditional Chinese medicine antibacterial component comprises, by weight, 1 part of semen euphorbiae lantu extract, 2 parts of Yunnan buddleja extract, 2 parts of Japanese ampelopsis extract, 2 parts of liquorice extract and 1 part of gentiana macrophylla extract.
Further, the formaldehyde inhibitor is formed by combining benzoguanamine and hydantoin according to the weight percentage of 1: 4.
Further, the butterfly fruit extract is an ethanol extract of butterfly fruit, and the specific extraction steps are as follows: pulverizing dried semen Oroxyli, sieving with 60 mesh sieve, adding 18 times of 95% ethanol solution, soaking for 80 hr, filtering, and centrifuging at 3000rpm/min for 15 min; collecting supernatant, concentrating by rotary evaporation to concentration of 1.5g/ml, and sterilizing the concentrated solution with microporous membrane to obtain semen Oroxyli extract.
Further, the preparation method of the sweet wormwood herb extract, the mulberry bark extract, the citrus peel extract and the moso bamboo leaf extract specifically comprises the following steps: drying the raw materials, respectively pulverizing, sieving with 100 mesh sieve to obtain powder, respectively, adding 95% ethanol solution, and ultrasonic extracting at 45 deg.C and 200W for 35min to obtain extractive solution; filtering the extractive solution, and concentrating under reduced pressure to obtain slurry; the slurry was mixed at a ratio of 1: dissolving the raw materials in deionized water at a volume ratio of 12, stirring, shaking, and sterilizing with microporous membrane filter to obtain the extracts.
Further, the preparation method of the aronia melanocarpa extract comprises the following steps: washing mud on the surface of the aronia melanocarpa with flowing water, introducing an ozone generator into sterile water to wash the aronia melanocarpa again, crushing pulp into pulp, adding deionized water according to 40% of the volume of the pulp, adding 2.5% of pectinase at the same time, stirring uniformly, and standing for 40min at 30 ℃; adding the supernatant into 95% ethanol solution, ultrasonic extracting at 40 deg.C and 200W ultrasonic power for 15min, and centrifuging at 4000rpm/min for 10 min; after concentrating the supernatant from the centrifugation to a semi-fluid slurry, the slurry was mixed at a ratio of 1: dissolving the extract in deionized water at a volume ratio of 20, stirring, shaking, and sterilizing with microporous membrane to obtain Aronia melanocarpa extract.
Further, the steps of extracting the moleplant seed extract, the yunnan buddleia extract, the ampelopsis japonica extract, the liquorice extract and the gentiana macrophylla extract are as follows: pulverizing dried semen Euphorbiae, Yunnan Buddleja, radix Ampelopsis, Glycyrrhrizae radix and radix Gentianae Marcrophyllae, sieving with 200 mesh sieve, adding 30 times of 90% ethanol solution, soaking for 75 hr, filtering, and centrifuging at 4000rpm/min for 12 min; collecting supernatant, concentrating by rotary evaporation to concentration of 0.8g/ml, and sterilizing the concentrated solution with microporous membrane filter to obtain Euphorbiae Lathyridis semen extract, YUNNANZUIYUCAO extract, radix Ampelopsis extract, Glycyrrhrizae radix extract and radix Gentianae Marcrophyllae extract.
A preparation method of a medical adhesive with high antibacterial performance is characterized by comprising the following steps:
step one, adding sodium alginate, lignin, tannic acid and a stabilizer into sterile water according to the proportion of parts, heating to 100 ℃, stirring for dissolving for 150min, and cooling to room temperature to obtain an aqueous solution A;
step two, adding poly (alpha-cyano isobutyl acrylate-alpha-cyano octyl acrylate), polyurethane and polyisoprene into the sea buckthorn seed oil according to the parts ratio, heating to 80 ℃, stirring for 75min, and cooling to room temperature to obtain a sea buckthorn seed oil solution B;
step three, uniformly mixing the aqueous solution A and the seabuckthorn seed oil solution B, adding the efficient antibacterial component and the formaldehyde inhibitor according to the proportion by parts, and stirring for 4 hours;
and step four, filtering and sterilizing the product obtained in the step three, subpackaging, sealing and packaging to obtain the medical adhesive with high antibacterial performance.
The medical alpha-cyanoacrylate glue has developed fast because of its unique advantages of single component, no solvent, no need of added catalyst, etc. and may be adhered fast at normal temperature. Moreover, the adhesive has the characteristics of wide adhesive range, high strength and instant curing, and more importantly, the medical adhesive has no toxic or side effect on organisms such as skin and the like. The particularity of the chemical structure determines the excellent property of the alpha-cyanoacrylate in adhesion, and the alpha-carbon atom in the molecular structure CNCH2CCOOR of the alpha-cyanoacrylate compound has extremely strong ability of attracting electrons, so that the chemical reaction can be immediately carried out when the alpha-cyanoacrylate compound contacts with a very small amount of anions. The basic substance of the organism, namely protein amino acid chains, are provided with a large number of electronegative groups-NH 2 and-COOH, and when the basic substance of the organism is contacted with alpha-cyanoacrylate, the reaction can be rapidly carried out, and the principle also enables the medical adhesive to be widely applied to clinic. The effect of α -cyanoacrylates on tissue is strongly related to the type and size of the alkyl group. Generally, the longer the ester carbon chain, the slower the polymerization reaction rate, the less irritation to the tissue, and the better the flexibility of the adhesive layer. The invention selects poly (alpha-cyano isobutyl acrylate-alpha-cyano octyl acrylate) as the main raw material in the system, is prepared by adopting an emulsification method, and has good biocompatibility and excellent antibacterial property. The alpha-cyanoacrylate is sterile, and has high bacteriostatic effect on golden yellow staphylococcus, white staphylococcus, tetrabacillus, bacillus subtilis and the like.
Polyurethane adhesives, which are considered to be one of the most promising biomedical materials to solve these problems, have excellent shear strength and impact resistance characteristics, are suitable for various structural adhesion fields, and have excellent flexibility. The polyurethane adhesive has excellent chemical adhesion with many materials containing active hydrogen because it contains isocyanate and carbamate groups with strong polarity and high chemical activity. The hydrogen bonding between the polyurethane and the bonded material can enhance the molecular cohesion, so that the bonding is firmer. In addition, the polyurethane adhesive also has the characteristics of good toughness, adjustability, simple and convenient bonding process, excellent low-temperature resistance, excellent stability and the like. Therefore, the invention selects a proper amount of added polyurethane components to achieve the purpose of improving the toughness and the bonding strength of the final product, and simultaneously, because the polyurethane has good biocompatibility, the polyurethane can be combined and fused with the antibacterial material more easily, thereby enhancing the antibacterial performance of the whole material.
The polyisoprene is the main rubber component of the natural latex, has high purity, is safe to human bodies, has antibacterial performance and is suitable for the fields of medicine, sanitation and the like with high requirements on the safety and comprehensive performance of latex products. The cyanoacrylate and the polyurethane are added together for modification, so that the stability of the polyisoprene rubber product can be greatly improved, the comprehensive performances of the cyanoacrylate such as polymerizability, cohesiveness, flexibility, various mechanical properties, biocompatibility and the like can be effectively improved, and the final medical rubber product can better meet various requirements of clinical medical rubber.
Titanium dioxide photocatalytic antibacterial agents and silver antibacterial agents are inorganic antibacterial agents, have the characteristics of safety, durability, broad spectrum and the like, and are widely applied in recent years. Nanometer titanium dioxide is also called nanometer titanium dioxide. In terms of size, fine particles generally having a significantly changed physicochemical property are produced, and have a size of 100 nm or less and a white loose powder in appearance. Has the effects of resisting ultraviolet rays, resisting bacteria, self-cleaning and resisting aging, and can be used in the fields of cosmetics, functional fibers, plastics, printing ink, coatings, paints, fine ceramics and the like. Under the action of ultraviolet rays, the malignant hela cells can be thoroughly killed by the ultrafine TiO2 with the concentration of 0.1mg/cm3, and the efficiency of killing cancer cells by TiO2 through photocatalysis is improved along with the increase of the addition amount of superoxide dismutase (SOD); the TiO2 is used for photocatalytic oxidation deep treatment of tap water, so that the number of bacteria in the water can be greatly reduced, and the tap water has no mutagenic effect after drinking, thereby reaching the standard of safe drinking water. The nano TiO2 added into the coating can be used for preparing antibacterial and antifouling coating with the functions of sterilization, antifouling, deodorization and self-cleaning, can be applied to places with dense and easily-propagated bacteria such as hospital wards, operating rooms, family toilets and the like, and can effectively kill harmful bacteria such as escherichia coli, yellow glucose bacteria and the like and prevent infection. Therefore, the nano TiO2 can purify air and has a deodorization function. The nano silver can kill more than 600 germs and can achieve the effect of more than 99 percent. The silver-loaded nano titanium dioxide solution greatly improves the defect of nano titanium dioxide in sterilization. The silver-loaded nano titanium dioxide is an excellent antibacterial material. The silver-loaded nano titanium dioxide antibacterial agent not only has antibacterial property, but also can be used as an anti-ultraviolet and anti-aging agent. The antibacterial agent is added to obtain good antibacterial performance and has long-term antibacterial effect.
Chlorhexidine acetate, also known as chlorhexidine acetate, is a biguanide disinfectant, and consists of chlorhexidine with highly symmetrical straight chain structure combined with two acetic acid molecules. Chlorhexidine acetate is a cationic surface active preservative and has the characteristics of wide antibacterial spectrum and strong antibacterial effect. Chlorhexidine acetate has obvious affinity to bacteria, and the action mechanism of the chlorhexidine acetate is that the chlorhexidine acetate is combined on the surface of the cell membrane of the bacteria, changes the permeability of the membrane, causes the outflow of intracellular substances, the precipitation and the agglutination of cytoplasm, and inhibits the growth of cells so as to kill the cells. A large number of studies at home and abroad show that the chlorhexidine acetate has strong inhibition effect on a plurality of gram-positive and gram-negative bacteria such as escherichia coli, staphylococcus aureus, streptococcus mutans, actinomycetes, pseudomonas aeruginosa and the like, and fungi such as candida albicans. Montmorillonite, also known as bentonite, is a natural mineral with a 2:1 layered silicate crystal structure, each unit cell has a layer of alumino-octahedra sandwiched between two silicon-oxygen tetrahedra connected by common oxygen atoms, and the close packing structure of the tetrahedra and octahedra makes it have highly ordered crystal arrangement with interlayer spacing of about 1 nm. The interlayer is exchangeable inorganic cation such as hydrated Na +, Ca2+, etc. Si4+ in a montmorillonite tetrahedron is often replaced by Al3+, Al3+ in an octahedron is often replaced by Mg2+, Fe3+, Fe2+, Ni2+, Li + and the like, so weak negative charges are generated between layers, and excessive negative charges are balanced by cations such as Na +, Ca2+ and Mg2+ which are dissociated between the layers, so that the montmorillonite is easy to generate organic montmorillonite by exchange reaction with alkyl quaternary ammonium salt or other organic cations. By utilizing the property, the montmorillonite can be combined with antibacterial drugs, biological macromolecules and the like to form a functional composite material, and the nano composite material with the function of controlling the slow release of the drugs is prepared.
The chlorhexidine acetate-montmorillonite nano antibacterial compound is a novel nano antibacterial drug, can effectively enhance the antibacterial property of chlorhexidine acetate and ensure the slow release property of an antibacterial material, and greatly improves the inhibition effect on gram-positive and gram-negative bacteria such as escherichia coli, staphylococcus aureus, streptococcus mutans, pseudomonas aeruginosa and the like and fungi such as candida albicans. Meanwhile, the chlorhexidine acetate-montmorillonite and polyurethane are added together, so that the prepared antibacterial material has long-acting, stable, safe and reliable performance and good mechanical property, and the material has low cost and is easier to process.
Graphene draws extensive attention from researchers in the fields of electronic devices, biology, medicine and the like due to its good electrical conductivity, thermal conductivity, light transmittance, biocompatibility, mechanical strength and the like. Graphene oxide (graphene oxide) is an important derivative of graphene, and the main structure of the graphene oxide is basically the same as that of graphene, except that epoxy bonds and hydroxyl groups are connected to the upper side and the lower side of a two-dimensional space infinitely extending basal plane in monoatomic arrangement, functional groups such as carboxyl groups are connected to the edge of the basal plane, the relationship between the graphene oxide and graphene is similar to that of a functionalized carbon nanotube and a carbon nanotube, and the graphene oxide has various characteristics and more commonality. Due to the high specific surface area and the abundant functional groups on the surface, the graphene oxide has wide application in the aspects of affinity to cells, enhancement to polymer nano materials and antibacterial performance. At present, scholars at home and abroad mainly apply the graphene oxide to the fields of electronic devices, reinforced materials, biomedicine and the like.
The medical material prepared by taking alginate as a raw material has good affinity with wounds, has the characteristic of rapid hemostasis, can be used for repairing tissues and organs of a human body, and has antibacterial property. The chemical molecular formula of sodium alginate is (C6H706Na) n, and the sodium alginate is a natural polysaccharide carbohydrate, and has the physicochemical properties that: the product is tasteless white or light yellow amorphous powder, is easily soluble in water, has strong hygroscopicity, is insoluble in organic solvents such as alcohol and chloroform, and has the characteristics of bioadhesion, biocompatibility, biodegradability and the like. Sodium alginate is used as a base material of drugs in the fields of medicine, biotechnology, and the like. Sodium alginate has been received in the United states pharmacopoeia as early as 1938. Alginic acid was incorporated in the british pharmacopoeia in 1963. Alginic acid is insoluble in water but swells when placed in water. Therefore, sodium alginate is used as a binding agent of tablets in the prior art, has unique advantages in thickening, and can prevent the viscosity reduction phenomenon in the product disinfection process due to good fluidity of sodium alginate. Meanwhile, sodium alginate can also be used as a stabilizer in the system, so that the storage and transportation of the product are more convenient.
The semen Oroxyli is also called as denseflower wall, fructus Pittospori Glabrati, semen Castaneae, and Acer Ginnala; pleasantly shining, pleasantly warm and humid climate, cold resistance, leaf gathering and growing of the top of the small branch, ellipse or oblong ellipse, whole margin, conicity, terminal growth, unisexual and homosexual flower, small male flower, fruit stone-shaped, single-spherical or double-spherical. Phalaenopsis is an arbor, the fruit is in a skewed egg-shaped sphere or double-sphere shape, the flower column base is in a beak shape, the seeds are nearly spherical, and the period of 5-11 months of flowers and fruits is provided. Distributed in the south of Guizhou, the northwest of Guangxi, the west and the southwest, and the southeast of Yunnan in China. It is also in evergreen forest of mountain slope or valley with elevation of 150 + 1000 m mountain or limestone mountain, Vietnam and Burma. The butterfly fruit is a few species, and only one species is used in China, so that the butterfly fruit is an economic tree with both grain and oil. The oil content of the seeds is 33-39%, the protein is 15-18%, the starch is 21-40%, and the sugar content is 2.5-12%. The butterfly fruit extract contains kaempferol, luteolin and other components, has high-efficiency inhibition effect on staphylococcus, escherichia coli, bacillus subtilis and other bacteria, and has strong antibacterial activity. Meanwhile, the methyl o-hydroxybenzoate in the butterfly fruit extract has a local stimulation effect, can promote local blood circulation, and has the effects of diminishing swelling, diminishing inflammation and relieving pain, and the tetrahydroisoquinoline compound has antifungal activity.
Aronia melanocarpa is also called aronia melanocarpa, Rosaceae, Aronia, perennial deciduous shrub. Originally produced in the northeast of north america, the boro coast to the pacific coast are distributed. The fruit contains polyphenol compounds such as procyanidine, anthocyanin and quercetin, and bioactive components such as organic acids, triterpenes and sterol compounds, wherein the total amount of the polyphenol compounds reaches 2.5-3.5%, and is higher than berries such as blueberry, cowberry and cranberry. The Aronia melanocarpa extract has high antibacterial activity on Escherichia coli and Staphylococcus aureus, has antioxidant and anti-inflammatory effects, and can also be used as antiseptic.
Herba Artemisiae Annuae is aerial part of Artemisia annua L of Compositae, and is annual herbaceous plant. The main source of antimalarial artemisinin. The sweet wormwood herb comprises the following chemical components: sesquiterpene lactones: artemisinin compounds such as artemisinin, artesunic acid A, artesunic acid B, and artesunic lactone. And (3) flavonoids: kaempferol (kaempferol), quercetin. The effective components in herba Artemisiae Annuae have high hemostatic effect and remarkable antibacterial effect.
The citrus peel contains a large amount of flavonoids, has the effects of resisting bacteria, diminishing inflammation, resisting allergy, easing pain, resisting viruses, resisting oxidation and resisting cancers, is an excellent raw material used as a medicament, and has excellent antibacterial activity on common bacteria such as escherichia coli, staphylococcus aureus, bacillus subtilis and the like. The citrus peel is produced from orange peel, sour pomelo peel or orange peel in western Hunan province.
The mulberry is a woody plant which grows for many years, the mulberry has been used as a main food source of the silkworm for a long time and plays a vital role in the development of the silk industry, and related researches on the mulberry are also developed around promoting the development of the silk industry. However, besides being a food source for silkworms, mulberry has many other important applications, and mulberry roots, mulberry barks, mulberry leaves and the like can be used as medicines. The mulberry bark contains various rare flavonoid components: the mulberry bark extract contains the components of morin, phellinus igniarius chromene, cyclosporine, sanggenon A-P, mulberrofuran A, B, C, K, N, 0 and M, P, Q, betulinic acid, mulberry polysaccharide and coumarin, and has strong inhibiting effect on staphylococcus aureus; has slight inhibition effect on typhoid bacillus and shigella flexneri. The mulberry bark furan A has stronger bacteriostatic activity on staphylococcus aureus and mycobacterium. Cyclosporin also has antifungal effect.
The antibacterial components of the Phyllostachys Pubescens leaf extract are flavonoids and anthraquinones. The bacteriostatic effect is achieved mainly by acting on the cell membrane of the microorganism. Isoflavone in the phyllostachys pubescens leaf extract can obviously inhibit the catalytic activity of tyrosinase, interrupt the oxidation process of melanin and inhibit the generation and formation of melanin, thereby preventing the formation of scars; the isoflavone has effects in resisting oxidation and enhancing immunity. The Phyllostachys Pubescens leaf contains abundant flavonoids, bioactive polysaccharides and other effective components, such as phenolic acid compounds, anthraquinone compounds, terpene lactone, special amino acids and active peptides, manganese, zinc, selenium, etc. The functional factors contained in the Phyllostachys Pubescens leaf mainly include flavone glycoside and coumarin lactone. The moso bamboo leaf extract has a plurality of excellent biological activity effects of bacteriostasis, free radical resistance, oxidation resistance and the like. The action mechanism of the phyllostachys pubescens leaf extract preservative is actually mainly influenced by the enzyme activity or the genetic particle structure of the cellular protoplasm part. The moso bamboo leaf extract is a natural bacteriostatic preservative, can effectively play a role in preserving as one active component, and does not need to be additionally added with chemical preservative components harmful to the skin.
Qianjin Zi, name of traditional Chinese medicine. Is dried mature seed of Euphorbiaceae plant Euphorbia lathyris L. The semen Euphorbiae contains diterpene alcohol and ester compounds, sterol compounds, coumarin compounds, flavonoid compounds, volatile oil compounds, fatty oil compounds, and other compounds. Has antibacterial, antiinflammatory, analgesic, repercussive, astringent, and hemostatic effects.
The yunnan buddleia is a plant of buddleia of Scrophulariaceae, and is a special plant in China. Is distributed in Yunnan and other places, grows in the area with the altitude of 1,000-2,500 meters, and mostly grows in mountain forest borders and hillside shrubs. The buddleja plant contains more bioactive components, including flavonoids, phenylpropanoid glycosides, terpenoids, saponins, lignans, sterols, long-chain fatty acid esters, alkaloids, etc. The Yunnan buddleja has antibacterial, antiinflammatory, tranquilizing and analgesic effects.
Ampelopsis japonica, also known as Japanese pachyrhizus, Ipomoea batatas, Ampelopsis japonica seedling, white root, Ficus simplicissima lour, etc., is the dry root tuber of Ampelopsis japonica of Vitaceae. Distributed in North China, northeast China, east China, south China, Shaanxi, Ningxia, Sichuan and the like. Collected in spring and autumn, removed silt and fine root, cut into longitudinal petals or oblique pieces, and dried in the sun. The radix Ampelopsis extract has effects of clearing heat and detoxicating, detumescence and resolving hard mass, promoting granulation and relieving pain, anti-inflammatory and antibacterial.
Radix Glycyrrhizae is also called "Gulao", radix Glycyrrhizae, Uralen radix Glycyrrhizae, and radix Glycyrrhizae. Leguminous and glycyrrhiza herbs belong to perennial herbs, and the roots and the rhizomes are strong, so the Chinese herbal medicine is a tonifying Chinese herbal medicine. The medicinal part is root and rhizome, and the medicinal root is cylindrical, 25-100 cm long and 0.6-3.5 cm in diameter. The skin has different elasticity, and the surface is reddish brown or grayish brown. The root and stem are cylindrical, the surface has bud mark, and the middle of the section has marrow. Light smell, sweet and special taste. The functions are mainly used for clearing away heat and toxic material, eliminating phlegm and relieving cough, and treating abdominal cavity and the like. It is a dry climate with preference for darkness and dampness, long sunshine and low temperature. Licorice root is mainly grown in arid and semi-arid desert grassland, desert edge and loess hilly land, and its root and rhizome are used as medicine. Researchers find that the effective components in the liquorice are flavonoids such as liquiritin, liquiritigenin and the like, triterpenoids such as glycyrrhetinic acid, glycyrrhizin and the like and some polysaccharides. The licorice extract has the effects of resisting ultraviolet rays, inhibiting tyrosinase activity, effectively resisting bacteria, improving inflammation and the like, and effectively promoting skin wound healing and improving scar conditions.
Gentiana macrophylla is a perennial herb of Gentianaceae, and is one of the main drugs for treating rheumatic arthralgia and other diseases. The quality of large-leaved gentian produced in Huang nan, especially in Qinghai, is the best. Is one of the important traditional Chinese medicines in China, and was recorded in Shen nong Ben Cao Jing. The gentiana macrophylla has the effects of dispelling wind, clearing away heat and toxic materials, resisting inflammation, inhibiting bacteria, relieving pain and the like. The main components of the extract are iridoid glycosides, triterpenes, sterols and saccharides, and the compounds have good antibacterial property and can effectively promote wound healing and skin growth.
Tannic acid belongs to a typical glucose acyl compound, and the structure of polyphenol hydroxyl group of tannic acid endows the tannic acid with a series of unique chemical characteristics and physiological activities, such as combination with protein, alkaloid and polysaccharide, so that the physicochemical behavior of the tannic acid is changed; can generate complexation and electrostatic interaction with various metal ions; has reducing and free radical capturing activity; has an amphiphilic structure and a plurality of derivatization reaction activities, and the like. The structure of a plurality of ortho phenolic hydroxyl groups of the tannic acid can be used as a polybase ligand to carry out complex reaction with metal ions. Two adjacent phenolic hydroxyl groups can form a stable five-membered ring chelate with metal ions in the form of oxygen anions, and the third phenolic hydroxyl group in the pyrogallol structure can promote the dissociation of the other two phenolic hydroxyl groups although not participating in the complexation, thereby promoting the formation and the stability of the complex. The ortho phenolic hydroxyl group in the pyrogallol structure of tannic acid is easily oxidized into quinone structure, and the oxidation reaction proceeds faster in the presence of enzymes, sufficient moisture, and at higher pH values (e.g., pH > 3.5), thereby consuming oxygen from the environment. The phenolic structure is an excellent hydrogen donor, has obvious inhibition effect on free radicals such as oxygen anions, hydroxyl free radicals and the like, and plays a role in protecting biological tissues. Tannic acid has a good radical trapping function due to the phenolic hydroxyl group, and can be used as an antioxidant. For example, food-grade tannic acid is used as wine antioxidant instead of sulfur dioxide.
The tannic acid contains a unique polyphenol hydroxyl structure, can be combined with biological macromolecules such as protein polysaccharide and the like and can also generate complexation with metal ions, the polyphenol hydroxyl structure contains a catechol structure, so the tannic acid has good reducibility, astringency and antibacterial property, is clinically used for treating local bleeding, and can be used for synthesizing gallic acid and pyrogallol (pyrogallic acid and pyrogallol). Tannic acid is a main raw material for preparing an antibacterial synergist in the pharmaceutical industry.
Lignin is the second biomass resource of the plant kingdom after cellulose, containing about 15-30% lignin in wood and about 12-20% lignin in annual plants; lignin is the only biomass resource in nature which can provide aromatic groups, but lignin can be biodegraded. The lignin has various functional groups and can be directly used as a curing agent, and the lignin is added into the resin to prepare the adhesive, so that the adhesive has good aging resistance and excellent antibacterial performance.
The sea buckthorn seed oil is a brown yellow to brown red transparent oily liquid obtained by subjecting sea buckthorn seeds to supercritical extraction or subcritical low-temperature extraction, and is a high-concentration product integrating active ingredients of sea buckthorn. Contains more than 140 bioactive components such as flavone, organic acid, alkaloid, sterol, triterpene, and various vitamins. The sea-buckthorn seed oil has obvious biological effect, high infection resistance, fast healing speed, and excellent and stable curative effect on tonsillitis, stomatitis, dermatitis, women's cervicitis, etc. The oleum Hippophae is a complex of vitamins and bioactive substances. It has effects of nourishing skin, promoting metabolism, resisting allergy, resisting bacteria, diminishing inflammation, promoting epithelial cell regeneration, repairing skin, maintaining skin acidic environment, and has strong permeability, so it is also important raw material for skin care. The total flavonoids of fructus Hippophae can directly capture superoxide radical and hydroxyl radical, and Ve and Vc superoxide dismutase (SOD) has effects of resisting oxidation, eliminating free radical on cell membrane, and effectively delaying aging. The VC content of sea-buckthorn is at the head of all fruits and vegetables and is known as the king of VC. VC is a natural whitening agent in vivo, can effectively inhibit the deposition of abnormal pigments on the skin and the activity of tyrosinase, and is helpful for the reduction of dopachrome, thereby reducing the formation of melanin and effectively whitening the skin. The sea buckthorn is rich in VE, carotene, carotenoid, beta-sitosterol, unsaturated fatty acid and the like, can inhibit subcutaneous tissue inflammation, enhance the anti-inflammatory effect of an inflammation center and obviously promote ulcer healing.
One class of organic compounds characterized by having a sulfonyl group and usually linked to two carbon atoms by sulfur (e.g., to two hydrocarbyl groups or a simple divalent group) are generally crystallographically stable compounds. Sulfones are often produced by oxidation of sulfides, with the intermediate product being a sulfoxide. The stabilizing agent selected by the invention adopts a composition of sulfone compounds, and the sulfone compounds are very effective antibacterial agents for a plurality of gram-positive and gram-negative bacteria. But the application of various sulfone compounds in various fields is influenced due to the toxicity problem of the various sulfone compounds. The selected sulfone compound composition is a nontoxic substance with excellent performance, and simultaneously, various mechanical properties of the product can be effectively improved by adding a cyanoacrylate substance and polyurethane. 3,3 '-diamino-4, 4' -dihydroxy diphenyl sulfone is nontoxic, can greatly enhance the heat resistance of the product and has good thermal stability; wherein dimethyl sulfolane has high boiling point, good thermal stability and no corrosiveness, and can improve the mechanical properties such as viscosity, flexibility and the like of the product while improving the stability after being added into a system.
Advantageous effects
Due to the adoption of the technical scheme, the invention has the following beneficial effects:
1. the high-antibacterial-performance medical adhesive is prepared by selecting special antibacterial components through repeated experiments, wherein the special antibacterial components comprise three antibacterial systems of 5 parts of special-effect nano antibacterial components, 12-18 parts of natural antibacterial components and 5-10 parts of traditional Chinese medicine antibacterial components, so that the long-acting and high-efficient antibacterial performance of the whole product is comprehensively improved, the comprehensive performance of the medical adhesive is improved, and the risk of a user is greatly reduced.
The silver-loaded nano titanium dioxide selected in the invention fully combines the advantages of two inorganic antibacterial agents and the special performance of a nano material, and simultaneously overcomes the defects that the electron pair of the titanium dioxide of the existing inorganic antibacterial material is easy to be compounded with a hole and the silver of the silver-loaded material is fast released and is easy to discolor; the chlorhexidine acetate-montmorillonite nano antibacterial compound is a novel nano antibacterial drug, and can effectively enhance the antibacterial property of chlorhexidine acetate and ensure the slow release property of an antibacterial material; graphene oxide has great advantages in affinity to cells and antibacterial performance due to its high specific surface area and abundant functional groups on the surface. The three specific antibacterial materials cooperate with each other to effectively ensure the broad-spectrum antibacterial performance, safety and long-term antibacterial effect of the product.
In addition, the montmorillonite and the graphene oxide can effectively improve the mechanical properties of the poly (isobutyl alpha-cyanoacrylate-octyl alpha-cyanoacrylate) and the polyurethane material, and play an effective role in enhancing. Meanwhile, the chlorhexidine acetate-montmorillonite and polyurethane are added together, so that the prepared antibacterial material has long-acting, stable, safe and reliable performance and good mechanical property, and the material has low cost and is easier to process.
2. The natural antibacterial components selected by the medical adhesive with high antibacterial performance comprise 2 parts of butterfly fruit extract, 2 parts of aronia melanocarpa extract, 3 parts of sweet wormwood herb extract, 2 parts of mulberry bark extract, 2 parts of citrus peel extract and 2 parts of lophatherum gracile extract, and the butterfly fruit extract contains kaempferol, luteolin and other components, has high-efficiency inhibiting effect on staphylococcus, escherichia coli, bacillus subtilis and other bacteria, and has strong antibacterial activity. Meanwhile, the methyl o-hydroxybenzoate in the butterfly fruit extract has a local stimulation effect, can promote local blood circulation, and has the functions of detumescence, antiphlogosis and analgesia, and the tetrahydroisoquinoline compounds have antifungal activity. The extract of Aronia melanocarpa contains polyphenols such as procyanidin, anthocyanin, and quercetin, and has high antibacterial activity. The herba Artemisiae Annuae extract has high content of sesquiterpene lactone and flavonoid, and has high hemostatic effect and remarkable antibacterial property. The citrus peel contains a large amount of flavonoids, and has high antibacterial and anti-inflammatory effects. The mulberry bark extract contains natural high-efficiency antibacterial substances such as mulberrin, mulberrypsin, cyclosporine, sanggenon, and mulberrofuran. The flavone glycoside and coumarin lactone in the phyllostachys pubescens leaf extract have excellent biological activity effects of bacteriostasis, free radical resistance, oxidation resistance and the like. The invention fully combines the effective components of six natural plants and fruits, has long-acting and high-efficiency antibacterial effects, has better compatibility to human bodies, and is safe without toxic and side effects.
Meanwhile, the aronia melanocarpa extract and the phyllostachys pubescens extract are natural antibacterial preservatives, can effectively play a role in corrosion prevention as active components of the bacteriostatic preservative, and chlorhexidine acetate is a cationic surface active preservative, so that a novel preservative system is built in the system, and preservative components harmful to skin do not need to be additionally added.
3. The traditional Chinese medicine antibacterial components selected by the medical adhesive with high antibacterial performance comprise 1 part of semen euphorbiae lathyris extract, 2 parts of Yunnan buddleja extract, 2 parts of Japanese ampelopsis extract, 2 parts of liquorice extract and 1 part of gentiana macrophylla extract. The Euphorbiae Lathyridis semen extract contains diterpene alcohol and ester compounds, sterol compounds, coumarin compounds, and flavonoid compounds, and has strong antibacterial, antiinflammatory, analgesic, repercussive, astringent, and hemostatic effects. The plant of genus Buddleja contains more bioactive components including flavonoids, phenylpropanoid phenol glycoside, terpenoids, saponins, lignans and alkaloids, and has antibacterial, antiinflammatory, tranquilizing and analgesic effects. The radix Ampelopsis extract has effects of clearing heat and detoxicating, detumescence and resolving hard mass, promoting granulation and relieving pain, anti-inflammatory and antibacterial. The licorice extract contains liquiritin, liquiritigenin and polysaccharide which can effectively resist bacteria and improve inflammation and the like, and can effectively promote skin wound healing and improve scar conditions. The gentiana macrophylla has the effects of dispelling wind, clearing away heat and toxic materials, resisting inflammation, inhibiting bacteria, relieving pain and the like. The main components of the extract are iridoid glycosides, triterpenes, sterols and saccharides, which have good antibacterial property and can effectively promote wound healing and skin growth. The invention fully combines the main antibacterial action of the five traditional Chinese medicine substances, and simultaneously fully utilizes the anti-inflammatory, analgesic and hemostatic actions of the moleplant seed extract; the anti-inflammatory and analgesic effects of the extract of the Yunnan buddleja officinalis; radix Ampelopsis extract has effects of clearing heat and detoxicating, detumescence and resolving hard mass, promoting granulation and relieving pain; the Glycyrrhrizae radix extract has effects of promoting skin wound healing and improving scar condition, and radix Gentianae Marcrophyllae has effects of dispelling pathogenic wind and promoting wound healing and skin growth. The traditional Chinese medicine antibacterial component assists the specific nano antibacterial component and the natural antibacterial component to form three antibacterial systems, and simultaneously has the effects of diminishing inflammation, easing pain, dispelling wind, promoting wound healing and skin growth, so that the product can become a medical adhesive with comprehensive functions, which is more suitable for clinical operation. The invention combines the natural antibacterial component and the traditional Chinese medicine antibacterial component, and the advantages of the product are more prominent, because the biological transdermal enhancer is derived from plant extracts, the biological transdermal enhancer has good biocompatibility, can not cause damage to skin, and has safety.
4. Other components selected by the medical adhesive with high antibacterial performance have high-efficiency antibacterial function and become an indispensable component of the whole antibacterial product. The effects of various antibacterial components are natural, and the medical adhesive with high antibacterial performance is prepared. The poly (alpha-cyano isobutyl acrylate-alpha-cyano octyl acrylate) is used as a main raw material in a system, is prepared by an emulsification method, and has good biocompatibility and excellent antibacterial performance. The alpha-cyanoacrylate is sterile, and has high bacteriostatic effect on golden yellow staphylococcus, white staphylococcus, tetrabacillus, bacillus subtilis and the like. The polyisoprene is the main rubber component of the natural latex, has high purity and safety to human bodies, has good biocompatibility and good antibacterial performance, and is easy to be combined and fused with antibacterial materials, so that the antibacterial performance of the whole material is enhanced.
The tannic acid contains a unique polyphenol hydroxyl structure, can be combined with biological macromolecules such as protein polysaccharide and the like and can also generate complexation with metal ions, the polyphenol hydroxyl structure contains a catechol structure, so the tannic acid has good reducibility, astringency and antibacterial property, is clinically used for treating local bleeding, and can be used for synthesizing gallic acid and pyrogallol (pyrogallic acid and pyrogallol). Tannic acid is a main raw material for preparing an antibacterial synergist in the pharmaceutical industry.
The lignin has various functional groups and can be directly used as a curing agent, and the lignin is added into the resin to prepare the adhesive, so that the adhesive has good aging resistance and excellent antibacterial performance.
The oleum Hippophae is a complex of vitamins and bioactive substances. It has effects in nourishing skin, promoting metabolism, resisting allergy, resisting bacteria, relieving inflammation, promoting epithelial cell regeneration, repairing skin, maintaining skin acidic environment, and has strong permeability.
Sodium alginate is a natural polysaccharide carbohydrate, and a medical material prepared by taking alginate as a raw material has good affinity with wounds, has the characteristic of rapid hemostasis, can be used for repairing tissues and organs of a human body, and has antibacterial property.
The stabilizing agent selected by the invention adopts a composition of sulfone compounds, and the sulfone compounds are very effective antibacterial agents for a plurality of gram-positive and gram-negative bacteria.
The formaldehyde inhibitors selected in the present invention are benzoguanamine and hydantoin, which themselves have broad spectrum antimicrobial activity.
In conclusion, all the raw materials selected by the invention have antibacterial performance, three antibacterial systems of a specific nano antibacterial component, a natural antibacterial component and a traditional Chinese medicine antibacterial component are added on the basis of the antibacterial performance of the medical adhesive, so that the antibacterial performance of the medical adhesive is comprehensively improved, and the medical adhesive with high antibacterial performance prepared by the invention has stronger and more efficient antibacterial performance and complete comprehensive performance under the synergistic effect.
5. The formaldehyde inhibitor selected by the medical adhesive with high antibacterial performance is formed by combining benzoguanamine and hydantoin according to the weight percentage of 1:4, and the benzoguanamine and the hydantoin have broad-spectrum antibacterial activity, so that the formaldehyde can be inhibited by synergistic cooperation of the two components, and a power assisting effect can be provided for the antibacterial performance of the medical adhesive with high antibacterial performance. It should be further noted that the unique polyphenol hydroxyl structure of tannic acid in the present invention is an effective formaldehyde inhibitor, the sea buckthorn seed oil contains various active ingredients, wherein triterpenes are also effective formaldehyde inhibitors, the natural antibacterial component and the traditional Chinese medicine antibacterial component in the present invention contain triterpenes and sterols, which can be used as formaldehyde inhibitors. Namely, the invention is equivalent to that a mutually synergistic formaldehyde inhibition system is constructed in the raw materials of the invention, the formaldehyde inhibitor, the tannic acid, the natural antibacterial component and the traditional Chinese medicine antibacterial component which are selected by the invention are combined to play a role of efficiently inhibiting formaldehyde, and the medical adhesive of the invention is fully proved to have extremely low toxicity, greatly reduced use risk and more suitable for human bodies.
The medical adhesive with high antibacterial performance has the bonding strength of more than 60N, the antibacterial rate to staphylococcus aureus of more than 98.5 percent and the antibacterial rate to escherichia coli of 99 percent, greatly improves the overall healing efficiency, has high biocompatibility, no stimulation to wound tissues, reduces the sensitization rate, has excellent comprehensive performance, meets the application requirement of clinic on the medical adhesive, reduces the infection risk of patients to the maximum extent by improving the antibacterial performance of the medical adhesive, and provides guarantee for reaching higher cure rate.
Detailed Description
The invention is described in detail below by means of specific examples:
example 1
A medical adhesive with high antibacterial performance comprises the following components in parts by weight:
45 parts of poly (alpha-isobutyl cyanoacrylate-alpha-octyl cyanoacrylate), 24 parts of efficient antibacterial component, 2 parts of polyurethane, 20 parts of polyisoprene, 2 parts of sodium alginate, 3 parts of lignin, 7 parts of tannic acid, 1 part of stabilizer, 1 part of formaldehyde inhibitor, 150 parts of sea-buckthorn seed oil and 180 parts of sterile water; the high-efficiency antibacterial component comprises 5 parts of specific nano antibacterial component, 12 parts of natural antibacterial component and 5 parts of traditional Chinese medicine antibacterial component; the specific nano antibacterial component is formed by mixing silver-loaded nano titanium dioxide, chlorhexidine acetate-montmorillonite and graphene oxide according to the weight part ratio of 2:2: 1; the natural antibacterial component comprises 2 parts of a butterfly fruit extract, 2 parts of a aronia melanocarpa extract, 3 parts of a sweet wormwood herb extract, 2 parts of a mulberry bark extract, 2 parts of a citrus peel extract and 2 parts of a moso bamboo leaf extract in parts by weight; the traditional Chinese medicine antibacterial component comprises, by weight, 1 part of semen euphorbiae lathyris extract, 2 parts of Yunnan buddleja extract, 2 parts of radix ampelopsis extract, 2 parts of liquorice extract and 1 part of gentiana macrophylla extract. The stabilizer is formed by combining 3,3 '-diamino-4, 4' -dihydroxy diphenyl sulfone and dimethyl sulfolane according to the weight part ratio of 3: 1; the formaldehyde inhibitor is formed by combining benzoguanamine and hydantoin according to the weight percentage of 1: 4.
The medical adhesive prepared by the embodiment is used for smearing wounds, and relevant performance tests are carried out, wherein the test results are as follows: the medical adhesive with high antibacterial performance has the bonding strength of 62N, the antibacterial rate to staphylococcus aureus of more than 98.3 percent and the antibacterial rate to escherichia coli of 99 percent.
Example 2
A medical adhesive with high antibacterial performance comprises the following components in parts by weight:
50 parts of poly (alpha-isobutyl cyanoacrylate-alpha-octyl cyanoacrylate), 29 parts of efficient antibacterial component, 3 parts of polyurethane, 21 parts of polyisoprene, 3 parts of sodium alginate, 4 parts of lignin, 8 parts of tannic acid, 1 part of stabilizer, 1 part of formaldehyde inhibitor, 180 parts of sea-buckthorn seed oil and 180 parts of sterile water; the high-efficiency antibacterial component comprises 5 parts of specific nano antibacterial component, 14 parts of natural antibacterial component and 7 parts of traditional Chinese medicine antibacterial component; the specific nano antibacterial component is formed by mixing silver-loaded nano titanium dioxide, chlorhexidine acetate-montmorillonite and graphene oxide according to the weight part ratio of 2:2: 1; the natural antibacterial component comprises 2 parts of a butterfly fruit extract, 2 parts of a aronia melanocarpa extract, 3 parts of a sweet wormwood herb extract, 2 parts of a mulberry bark extract, 2 parts of a citrus peel extract and 2 parts of a moso bamboo leaf extract in parts by weight; the traditional Chinese medicine antibacterial component comprises, by weight, 1 part of semen euphorbiae lathyris extract, 2 parts of Yunnan buddleja extract, 2 parts of radix ampelopsis extract, 2 parts of liquorice extract and 1 part of gentiana macrophylla extract. The stabilizer is formed by combining 3,3 '-diamino-4, 4' -dihydroxy diphenyl sulfone and dimethyl sulfolane according to the weight part ratio of 3: 1; the formaldehyde inhibitor is formed by combining benzoguanamine and hydantoin according to the weight percentage of 1: 4.
The medical adhesive prepared by the embodiment is used for smearing wounds, and relevant performance tests are carried out, wherein the test results are as follows: the medical adhesive with high antibacterial performance has the bonding strength of 62.6N, the antibacterial rate to staphylococcus aureus of more than 98.5 percent and the antibacterial rate to escherichia coli of 99 percent.
Example 3
A medical adhesive with high antibacterial performance comprises the following components in parts by weight:
53 parts of poly (alpha-isobutyl cyanoacrylate-alpha-octyl cyanoacrylate), 32 parts of efficient antibacterial component, 4 parts of polyurethane, 23 parts of polyisoprene, 3 parts of sodium alginate, 5 parts of lignin, 9 parts of tannic acid, 1 part of stabilizer, 1 part of formaldehyde inhibitor, 190 parts of sea-buckthorn seed oil and 180 parts of sterile water; the high-efficiency antibacterial component comprises 5 parts of specific nano antibacterial component, 16 parts of natural antibacterial component and 9 parts of traditional Chinese medicine antibacterial component; the specific nano antibacterial component is formed by mixing silver-loaded nano titanium dioxide, chlorhexidine acetate-montmorillonite and graphene oxide according to the weight part ratio of 2:2: 1; the natural antibacterial component comprises 2 parts of a butterfly fruit extract, 2 parts of a aronia melanocarpa extract, 3 parts of a sweet wormwood herb extract, 2 parts of a mulberry bark extract, 2 parts of a citrus peel extract and 2 parts of a moso bamboo leaf extract in parts by weight; the traditional Chinese medicine antibacterial component comprises, by weight, 1 part of semen euphorbiae lathyris extract, 2 parts of Yunnan buddleja extract, 2 parts of radix ampelopsis extract, 2 parts of liquorice extract and 1 part of gentiana macrophylla extract. The stabilizer is formed by combining 3,3 '-diamino-4, 4' -dihydroxy diphenyl sulfone and dimethyl sulfolane according to the weight part ratio of 3: 1; the formaldehyde inhibitor is formed by combining benzoguanamine and hydantoin according to the weight percentage of 1: 4.
The medical adhesive prepared by the embodiment is used for smearing wounds, and relevant performance tests are carried out, wherein the test results are as follows: the medical adhesive with high antibacterial performance has the bonding strength of 63.3N, the antibacterial rate to staphylococcus aureus of more than 98.7 percent and the antibacterial rate to escherichia coli of 99 percent.
Example 4
A medical adhesive with high antibacterial performance comprises the following components in parts by weight:
55 parts of poly (alpha-isobutyl cyanoacrylate-alpha-octyl cyanoacrylate), 36 parts of efficient antibacterial component, 5 parts of polyurethane, 25 parts of polyisoprene, 4 parts of sodium alginate, 6 parts of lignin, 10 parts of tannic acid, 1 part of stabilizer, 1 part of formaldehyde inhibitor, 200 parts of sea buckthorn seed oil and 180 parts of sterile water; the high-efficiency antibacterial component comprises 5 parts of specific nano antibacterial component, 18 parts of natural antibacterial component and 10 parts of traditional Chinese medicine antibacterial component; the specific nano antibacterial component is formed by mixing silver-loaded nano titanium dioxide, chlorhexidine acetate-montmorillonite and graphene oxide according to the weight part ratio of 2:2: 1; the natural antibacterial component comprises 2 parts of a butterfly fruit extract, 2 parts of a aronia melanocarpa extract, 3 parts of a sweet wormwood herb extract, 2 parts of a mulberry bark extract, 2 parts of a citrus peel extract and 2 parts of a moso bamboo leaf extract in parts by weight; the traditional Chinese medicine antibacterial component comprises, by weight, 1 part of semen euphorbiae lathyris extract, 2 parts of Yunnan buddleja extract, 2 parts of radix ampelopsis extract, 2 parts of liquorice extract and 1 part of gentiana macrophylla extract. The stabilizer is formed by combining 3,3 '-diamino-4, 4' -dihydroxy diphenyl sulfone and dimethyl sulfolane according to the weight part ratio of 3: 1; the formaldehyde inhibitor is formed by combining benzoguanamine and hydantoin according to the weight percentage of 1: 4.
The medical adhesive prepared by the embodiment is used for smearing wounds, and relevant performance tests are carried out, wherein the test results are as follows: the medical adhesive with high antibacterial performance has the bonding strength of 64N, the antibacterial rate to staphylococcus aureus of more than 98.9 percent and the antibacterial rate to escherichia coli of 99 percent.
In the above embodiments
The specific extraction steps of the butterfly fruit extract are as follows: pulverizing dried semen Oroxyli, sieving with 60 mesh sieve, adding 18 times of 95% ethanol solution, soaking for 80 hr, filtering, and centrifuging at 3000rpm/min for 15 min; collecting supernatant, concentrating by rotary evaporation to concentration of 1.5g/ml, and sterilizing the concentrated solution with microporous membrane to obtain semen Oroxyli extract.
The preparation method of the sweet wormwood herb extract, the mulberry bark extract, the citrus peel extract and the moso bamboo leaf extract specifically comprises the following steps: drying the raw materials, respectively pulverizing, sieving with 100 mesh sieve to obtain powder, respectively, adding 95% ethanol solution, and ultrasonic extracting at 45 deg.C and 200W for 35min to obtain extractive solution; filtering the extractive solution, and concentrating under reduced pressure to obtain slurry; the slurry was mixed at a ratio of 1: dissolving the raw materials in deionized water at a volume ratio of 12, stirring, shaking, and sterilizing with microporous membrane filter to obtain the extracts.
The preparation method of the aronia melanocarpa extract comprises the following steps: washing mud on the surface of the aronia melanocarpa with flowing water, introducing an ozone generator into sterile water to wash the aronia melanocarpa again, crushing pulp into pulp, adding deionized water accounting for 40% of the volume of the pulp and pectinase 2.5%, uniformly stirring, and standing at 30 ℃ for 40 min; adding the supernatant into 95% ethanol solution, ultrasonic extracting at 40 deg.C and 200W ultrasonic power for 15min, and centrifuging at 4000rpm/min for 10 min; after concentrating the supernatant from the centrifugation to a semi-fluid slurry, the slurry was mixed at a ratio of 1: dissolving the extract in deionized water at a volume ratio of 20, stirring, shaking, and sterilizing with microporous membrane to obtain Aronia melanocarpa extract.
The concrete extraction steps of the moleplant seed extract, the yunnan buddleia extract, the ampelopsis japonica extract, the liquorice extract and the gentiana macrophylla extract are as follows: pulverizing dried semen Euphorbiae, Yunnan Buddleja, radix Ampelopsis, Glycyrrhrizae radix and radix Gentianae Marcrophyllae, sieving with 200 mesh sieve, adding 30 times of 90% ethanol solution, soaking for 75 hr, filtering, and centrifuging at 4000rpm/min for 12 min; collecting supernatant, concentrating by rotary evaporation to concentration of 0.8g/ml, and sterilizing the concentrated solution with microporous membrane filter to obtain Euphorbiae Lathyridis semen extract, YUNNANZUIYUCAO extract, radix Ampelopsis extract, Glycyrrhrizae radix extract and radix Gentianae Marcrophyllae extract.
The preparation method of the medical adhesive with high antibacterial performance comprises the following steps:
step one, adding sodium alginate, lignin, tannic acid and a stabilizer into sterile water according to the proportion of parts, heating to 100 ℃, stirring for dissolving for 150min, and cooling to room temperature to obtain an aqueous solution A;
step two, adding poly (alpha-cyano isobutyl acrylate-alpha-cyano octyl acrylate), polyurethane and polyisoprene into the sea buckthorn seed oil according to the parts ratio, heating to 80 ℃, stirring for 75min, and cooling to room temperature to obtain a sea buckthorn seed oil solution B;
step three, uniformly mixing the aqueous solution A and the seabuckthorn seed oil solution B, adding the efficient antibacterial component and the formaldehyde inhibitor according to the proportion by parts, and stirring for 4 hours;
and step four, filtering and sterilizing the product obtained in the step three, subpackaging, sealing and packaging to obtain the medical adhesive with high antibacterial performance.
Performance testing
The medical adhesive with high antibacterial performance has the bonding strength of more than 60N, the antibacterial rate to staphylococcus aureus of more than 98 percent and the antibacterial rate to escherichia coli of 99 percent, greatly reduces the risk of users, improves the whole healing efficiency, has good biocompatibility, no stimulation to wound tissues and excellent comprehensive performance, meets the application requirement of clinic on the medical adhesive, can reduce the infection risk of patients to the maximum extent by improving the antibacterial performance of the medical adhesive, and provides guarantee for reaching higher cure rate.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by the present specification, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (1)
1. A preparation method of a medical adhesive with high antibacterial performance comprises the following components in parts by weight: 45-55 parts of poly (alpha-isobutyl cyanoacrylate-alpha-octyl cyanoacrylate), 24-36 parts of efficient antibacterial component, 2-5 parts of polyurethane, 20-25 parts of polyisoprene, 2-4 parts of sodium alginate, 3-6 parts of lignin, 7-10 parts of tannic acid, 1 part of stabilizer, 1 part of formaldehyde inhibitor, 150 parts of sea-buckthorn seed oil and 180 parts of sterile water;
the high-efficiency antibacterial component comprises 5 parts of specific nano antibacterial component, 12-18 parts of natural antibacterial component and 5-10 parts of traditional Chinese medicine antibacterial component;
the specific nano antibacterial component is prepared by mixing silver-loaded nano titanium dioxide, chlorhexidine acetate-montmorillonite and graphene oxide according to the weight part ratio of 2:2: 1;
the natural antibacterial component comprises 2 parts of a butterfly fruit extract, 2 parts of a aronia melanocarpa extract, 3 parts of a sweet wormwood herb extract, 2 parts of a mulberry bark extract, 2 parts of a citrus peel extract and 2 parts of a moso bamboo leaf extract in parts by weight;
the traditional Chinese medicine antibacterial component comprises, by weight, 1 part of semen euphorbiae lantu extract, 2 parts of Yunnan buddleja extract, 2 parts of Japanese ampelopsis extract, 2 parts of liquorice extract and 1 part of gentiana macrophylla extract;
the method comprises the following steps:
step one, adding sodium alginate, lignin, tannic acid and a stabilizer into sterile water according to the proportion of parts, heating to 100 ℃, stirring for dissolving for 150min, and cooling to room temperature to obtain an aqueous solution A;
step two, adding poly (alpha-cyano isobutyl acrylate-alpha-cyano octyl acrylate), polyurethane and polyisoprene into the sea buckthorn seed oil according to the parts ratio, heating to 80 ℃, stirring for 75min, and cooling to room temperature to obtain a sea buckthorn seed oil solution B;
step three, uniformly mixing the aqueous solution A and the seabuckthorn seed oil solution B, adding the efficient antibacterial component and the formaldehyde inhibitor according to the proportion by parts, and stirring for 4 hours;
and step four, filtering and sterilizing the product obtained in the step three, subpackaging, sealing and packaging to obtain the medical adhesive with high antibacterial performance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810642868.XA CN108452369B (en) | 2018-06-21 | 2018-06-21 | Preparation method of medical adhesive with high antibacterial performance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810642868.XA CN108452369B (en) | 2018-06-21 | 2018-06-21 | Preparation method of medical adhesive with high antibacterial performance |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108452369A CN108452369A (en) | 2018-08-28 |
CN108452369B true CN108452369B (en) | 2021-02-09 |
Family
ID=63216241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810642868.XA Active CN108452369B (en) | 2018-06-21 | 2018-06-21 | Preparation method of medical adhesive with high antibacterial performance |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108452369B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2021350175A1 (en) * | 2020-09-26 | 2023-05-18 | Mussel Polymers, Inc. | Polymers for bonding coral |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5762955A (en) * | 1994-02-04 | 1998-06-09 | Smith; Stephen Jay | Method for application and maintenance of medication on body tissue |
CN100371028C (en) * | 2002-04-02 | 2008-02-27 | 昆明贝依玛生物医学材料有限公司 | Medical surgical adhesive |
EP1898969A2 (en) * | 2005-07-01 | 2008-03-19 | Cinvention Ag | Medical devices comprising a reticulated composite material |
CN1318099C (en) * | 2005-07-29 | 2007-05-30 | 商菁华 | Adhesive |
US20140212467A1 (en) * | 2011-09-08 | 2014-07-31 | Corning Incorporated | Antimicrobial Composite Material |
WO2013174430A1 (en) * | 2012-05-23 | 2013-11-28 | Henkel Ag & Co. Kgaa | An article comprising a film on a carrier or release substrate |
CN104937056B (en) * | 2012-12-14 | 2018-03-02 | 东亚合成株式会社 | Adhesive composition |
CN106039391A (en) * | 2016-06-21 | 2016-10-26 | 林春梅 | Anti-bacterial high-viscosity medical glue and preparation method thereof |
-
2018
- 2018-06-21 CN CN201810642868.XA patent/CN108452369B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108452369A (en) | 2018-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Natural extracts for antibacterial applications | |
Chhikara et al. | Bioactive compounds and pharmacological and food applications of Syzygium cumini–a review | |
Sandhu et al. | Equisetum arvense: pharmacology and phytochemistry-a review | |
KR101233857B1 (en) | Cosmetic composition with natural orientalplant extract | |
CN103356442B (en) | Production method for sunscreen cream with plant extracts as main functional components | |
KR101952695B1 (en) | Composition having anti-wrinkle effects using the natural plant extract and cosmetic composition comprising the same | |
KR20090055309A (en) | Skin cosmetic composition for skin whitening and wrinkle improvement | |
CN113521164B (en) | Tibetan medicine composition with antibacterial effect and preparation method and application thereof | |
KR101931549B1 (en) | Composition for skin whitening using the natural plant extract and whitening cosmetic composition comprising the same | |
Upadhyay | Nutraceutical, therapeutic, and pharmaceutical potential of Aloe vera: A review | |
Yadav et al. | Herbal wound healing agents | |
KR101903987B1 (en) | Functional cosmetic compositions for preventing skin aging using the natural fermented extracts and the cosmetics using the same | |
KR101795917B1 (en) | Antimicrobial compositions for perfume containing natural material extract | |
KR101347036B1 (en) | Composition of cosmetic using natural complex extract as anti-oxidant agent | |
CN108686257B (en) | Medical adhesive with high antibacterial performance | |
Raisagar et al. | Comparative study of wound-healing effect of bark extracts of Ficus religiosa & Ficus benghalensis by mice model | |
Nagansurkar et al. | Some Typical Medicinal Plants And Their Active Constituent’s Ability For Wound Healing | |
Singh et al. | The portent plant with a purpose: Aloe vera | |
Sahu et al. | A mini-review on phytochemical screening, biological activity, and therapeutic capability of Hibiscus: An ornamental plant species | |
Narzary et al. | Acknowledging the use of botanicals to treat diabetic foot ulcer during the 21st century: A systematic review | |
CN108452369B (en) | Preparation method of medical adhesive with high antibacterial performance | |
Mikaili et al. | Pharmacological review of medicinal trees spontaneous in Iran: a historical and modern study | |
KR20160118417A (en) | Manufacturing Method and Composion for Viper Venom Liquid Mixture | |
Khalid et al. | Phytochemical and pharmacological importance of Malva neglecta: An updated review | |
WS et al. | THE SCREENING OF LOCAL HERBS IN TREATING NON HEALING WOUNDS AND DIABETIC FOOT ULCERS COMPLICATIONS USING NIH 3T3 MOUSE FIBROBLAST AND RAW 264.7 MOUSE MACROPHAGE CELLS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |